BMC Cancer

Papers
(The H4-Index of BMC Cancer is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis234
Chemotherapy in the treatment of different histological types of appendiceal cancers: a SEER based study136
Lnc-SELPLG-2:1 enhanced osteosarcoma oncogenesis via hsa-miR-10a-5p and the BTRC cascade110
Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification107
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer95
Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy85
Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors83
Exposure–response analyses of cabozantinib in patients with metastatic renal cell cancer80
Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway78
Associations between female lung cancer risk and sex steroid hormones: a systematic review and meta-analysis of the worldwide epidemiological evidence on endogenous and exogenous sex steroid hormones74
A metabolome-wide case-control study of african american breast cancer patients71
System-wide identification of novel de-ubiquitination targets for USP10 in gastric cancer metastasis through multi-omics screening69
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study67
The gene expression profile and cell of origin of canine peripheral T-cell lymphoma62
Survival benefit of adjuvant TACE for patients with hepatocellular carcinoma and child-pugh B7 or B8 after hepatectomy61
Effects of neoadjuvant radiochemotherapy for anorectal function in locally advanced rectal cancer patients: a study protocol for a prospective, observational, controlled, multicentre study58
Changing patterns of nasopharyngeal carcinoma incidence in Hong Kong: a 30-year analysis and future projections58
Development and psychometric properties of Health-Promoting Lifestyle Scale in Colorectal Cancer Survivors (HPLS-CRCS): a mixed-method study57
Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma—randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol57
ESR1 PvuII polymorphism: from risk factor to prognostic and predictive factor of the success of primary systemic therapy in advanced breast cancer54
Single-copy Snail upregulation causes partial epithelial-mesenchymal transition in colon cancer cells54
Network Evolution Model-based prediction of tumor mutation burden from radiomic-clinical features in endometrial cancers53
Adult breast, lung, pancreatic, upper and lower gastrointestinal cancer patients with hospitalized venous thromboembolism in the national French hospital discharge database53
Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer52
Antibiotic use during radical surgery in stage I-III colorectal cancer: correlation with outcomes?51
Association of oxaliplatin-containing adjuvant duration with post-treatment fall-related injury and fracture in patients with stage III colon cancer: a population-based retrospective cohort study51
Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0–4): study protocol for a prospective, multicentre, random51
Rapid and label-free detection of gastrointestinal stromal tumor via a combination of two-photon microscopy and imaging analysis51
Exploring optimal administration timing of pegylated recombinant human granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in early breast cancer treated with pharmorubicin and 48
Optimal treatment strategies for hepatoid adenocarcinoma of the lung: insights from a comprehensive analysis48
Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients46
Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer46
Tracking the dropout patients of neoadjuvant chemotherapy with locally advanced oral cavity cancer45
A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherap45
A stable gene set for prediction of prognosis and efficacy of chemotherapy in gastric cancer44
Effect of PR status on the prognosis of advanced ER-high HER2-negative breast cancer patients receiving CDK4/6 inhibitor combined with endocrine as first-line therapy44
The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma43
Deep learning based on intratumoral heterogeneity predicts histopathologic grade of hepatocellular carcinoma43
Oral cavity and oropharyngeal carcinoma disparities in age and survival in Indigenous and non-Indigenous populations of Queensland43
Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness42
Increased use of diagnostic CT imaging increases the detection of stage IA lung cancer: pathways and patient characteristics42
Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up41
Correlation between overall survival and quality of life in colon cancer patients with chemotherapy41
Hsa_circ_0004872 alleviates meningioma progression by sponging miR-190a-3p/PTEN signaling41
0.056621074676514